SEC Form 4 · accession 0001437749-26-022164
Monopar Therapeutics · MNPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole Sweeny
Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001645469
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $87.68 | Jun 26, 2026 | A | 1,284 | A | — | Jun 26, 2036 | Common Stock | 1,284 | 1,284 | D |
Explanation of responses
- F1Options vest 50% on September 30, 2026, and 50% on December 31, 2026.